Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × INDUSTRY × Stomatitis × Clear all

Phase

Phase 2 20 Phase NA 7 Phase 3 6 Phase 4 5 Phase 1/2 3 Phase 1 3 Phase 2/3 2 Phase EARLY_PHASE1 1

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 17 Solid Tumor 14 Breast Neoplasms 13 Stomach Neoplasms 10 Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Sarcoma 9 Melanoma 9 Lymphoma, B-Cell 9 Head and Neck Neoplasms 9 Colorectal Neoplasms 9 Pancreatic Neoplasms 8 Lymphoma 7 Lung Neoplasms 7 Leukemia, Myeloid, Acute 7 Carcinoma, Non-Small-Cell Lung 7 Burkitt Lymphoma 6 Recurrence 5 Prostatic Neoplasms 5 Ovarian Neoplasms 5 Glioblastoma 5 Carcinoma, Hepatocellular 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Osteosarcoma 4 Lymphoma, Non-Hodgkin 4 Leukemia 4 Hematologic Neoplasms 4 Glioma 4 Endometrial Neoplasms 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05104268 2024-02-20

MDOM

E2Bio Life Sciences, LLC

Phase EARLY_PHASE1 Withdrawn

Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡